What is Artiva Biotherapeutics, Inc.'s net investment in lease?

Artiva Biotherapeutics, Inc. (ARTV) reported net investment in lease of $9.88M in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s net investment in lease changed year-over-year?

Artiva Biotherapeutics, Inc.'s net investment in lease decreased by 26.7% year-over-year, from $13.48M to $9.88M.

What is the long-term trend for Artiva Biotherapeutics, Inc.'s net investment in lease?

Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s net investment in lease has grown at a -20.2% compound annual growth rate (CAGR), from $16.55M to $10.53M.

Artiva Biotherapeutics, Inc. ARTV Net Investment in Lease

Net Investment in Lease at other companies

Kyverna Therapeutics, Inc.KYTX

——

Allogene TherapeuticsALLO

——

Immix Biopharma, Inc.IMMX

——

ImmunityBio, Inc.IBRX

——

Cullinan Therapeutics, Inc.CGEM

——

Climb Bio, Inc.CLYM

——

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s net investment in lease?: Artiva Biotherapeutics, Inc. (ARTV) reported net investment in lease of $9.88M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s net investment in lease changed year-over-year?: Artiva Biotherapeutics, Inc.'s net investment in lease decreased by 26.7% year-over-year, from $13.48M to $9.88M.
What is the long-term trend for Artiva Biotherapeutics, Inc.'s net investment in lease?: Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s net investment in lease has grown at a -20.2% compound annual growth rate (CAGR), from $16.55M to $10.53M.